New tools for pathology: a user's review of a highly multiplexed method for in situ analysis of protein and RNA expression in tissue

Tumor cell heterogeneity and tumor cell–stromal interactions are being explored as determinants of disease progression and treatment resistance in solid tumor and hematological malignancies. As such, tools simultaneously capable of highly multiplexed profiling of tissues' protein and RNA content, as well as interrogation of rare or single cells, are required to precisely characterize constituent tumor cell populations, infiltrating lymphocytes and stromal elements. Access to spatial relationships will enable more precise characterization of tumors, support patient stratification and may help to identify novel drug targets. Multiple platforms are being developed to address these critical unmet needs. The NanoString digital spatial profiling (DSP) platform enables highly multiplexed, spatial assessment of protein and/or RNA targets in tissues by detecting oligonucleotide barcodes conjugated via a photocleavable linker to primary antibodies or nucleic acid probes. Although this platform enables high‐dimensional spatial interrogation of tissue protein and RNA expression, a detailed understanding of its composition, function and chemistry is advisable to guide experimental design and data interpretation. The purpose of this review is to provide an independent, comprehensive description of the DSP technology, including an overview of NanoString's capture and antibody barcode conjugation chemistries, experimental workflow, data output and analysis methods. The DSP technology will be discussed in the context of other highly multiplexed immunohistochemistry methods, including imaging mass cytometry and multiplexed ion beam imaging, to inform potential users of the advantages and limitations of each. Additional issues such as preanalytical variability, sampling and specimen adequacy will be considered with respect to the platforms to inform potential experimental design. Copyright © 2018 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.

[1]  Donald A Berry,et al.  NCCN Task Force Report: Estrogen Receptor and Progesterone Receptor Testing in Breast Cancer by Immunohistochemistry. , 2009, Journal of the National Comprehensive Cancer Network : JNCCN.

[2]  Alan Sharpe,et al.  High-Frequency Targetable EGFR Mutations in Sinonasal Squamous Cell Carcinomas Arising from Inverted Sinonasal Papilloma. , 2015, Cancer research.

[3]  Etienne Becht,et al.  Immune and Stromal Classification of Colorectal Cancer Is Associated with Molecular Subtypes and Relevant for Precision Immunotherapy , 2016, Clinical Cancer Research.

[4]  C. Brennan,et al.  Genome-wide methylomic and transcriptomic analyses identify subtype-specific epigenetic signatures commonly dysregulated in glioma stem cells and glioblastoma , 2018, Epigenetics.

[5]  Ralph Weissleder,et al.  Cancer Cell Profiling by Barcoding Allows Multiplexed Protein Analysis in Fine-Needle Aspirates , 2014, Science Translational Medicine.

[6]  Jennifer L. Osborn,et al.  Direct multiplexed measurement of gene expression with color-coded probe pairs , 2008, Nature Biotechnology.

[7]  M. Seldin,et al.  Molecular characterization of murine and human OX40/OX40 ligand systems: identification of a human OX40 ligand as the HTLV‐1‐regulated protein gp34. , 1994, The EMBO journal.

[8]  A. Barclay,et al.  Characterization of the MRC OX40 antigen of activated CD4 positive T lymphocytes‐‐a molecule related to nerve growth factor receptor. , 1990, The EMBO journal.

[9]  Qing Li,et al.  Highly multiplexed single-cell analysis of formalin-fixed, paraffin-embedded cancer tissue , 2013, Proceedings of the National Academy of Sciences.

[10]  P. Wen,et al.  Drug sensitivity of single cancer cells is predicted by changes in mass accumulation rate , 2016, Nature Biotechnology.

[11]  Bernd Bodenmiller,et al.  Automatic single cell segmentation on highly multiplexed tissue images , 2015, Cytometry. Part A : the journal of the International Society for Analytical Cytology.

[12]  Bernd Bodenmiller,et al.  Simultaneous Multiplexed Imaging of mRNA and Proteins with Subcellular Resolution in Breast Cancer Tissue Samples by Mass Cytometry , 2018, Cell systems.

[13]  Ambrose J. Carr,et al.  Single-Cell Map of Diverse Immune Phenotypes in the Breast Tumor Microenvironment , 2018, Cell.

[14]  Joseph M. Beechem,et al.  Abstract 3434: Digital spatial profiling platform allows for spatially resolved, high-plex quantification of mRNA distribution and abundance on FFPE and fresh frozen tissue sections , 2018 .

[15]  U. Häfeli,et al.  Heterogeneous distribution of trastuzumab in HER2-positive xenografts and metastases: role of the tumor microenvironment , 2018, Clinical & Experimental Metastasis.

[16]  Sean C. Bendall,et al.  Multiplexed ion beam imaging of human breast tumors , 2014, Nature Medicine.

[17]  Shawn M. Gillespie,et al.  Single-cell RNA-seq highlights intratumoral heterogeneity in primary glioblastoma , 2014, Science.

[18]  D. Rimm,et al.  Quantitative Assessment Shows Loss of Antigenic Epitopes as a Function of Pre-analytic Variables , 2011, Laboratory Investigation.

[19]  A. Chott,et al.  Effect of formalin tissue fixation and processing on immunohistochemistry. , 2000, The American journal of surgical pathology.

[20]  A. Abyzov,et al.  Single-cell analysis of targeted transcriptome predicts drug sensitivity of single cells within human myeloma tumors , 2016, Leukemia.

[21]  I. Goldstein,et al.  Differential expression of an α-galactosyl-containing trisaccharide on high- and low-malignant murine sarcoma cells: Identification and regulation , 2004, Clinical & Experimental Metastasis.

[22]  G. Turashvili,et al.  Nucleic acid quantity and quality from paraffin blocks: defining optimal fixation, processing and DNA/RNA extraction techniques. , 2012, Experimental and molecular pathology.

[23]  Pradeep S Rajendran,et al.  Single-cell dissection of transcriptional heterogeneity in human colon tumors , 2011, Nature Biotechnology.

[24]  Ludmila V. Danilova,et al.  Multidimensional, quantitative assessment of PD-1/PD-L1 expression in patients with Merkel cell carcinoma and association with response to pembrolizumab , 2018, Journal of Immunotherapy for Cancer.

[25]  Franziska Michor,et al.  Unravelling subclonal heterogeneity and aggressive disease states in TNBC through single-cell RNA-seq , 2018, Nature Communications.

[26]  H. P. Fell,et al.  Cloning of mouse Ox40: a T cell activation marker that may mediate T-B cell interactions. , 1993, Journal of immunology.

[27]  J. Webster,et al.  Effects of Prolonged Formalin Fixation on Diagnostic Immunohistochemistry in Domestic Animals , 2009, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[28]  Bernd Bodenmiller,et al.  AirLab: a cloud-based platform to manage and share antibody-based single-cell research , 2016, Genome Biology.

[29]  I. Mellman,et al.  Elements of cancer immunity and the cancer–immune set point , 2017, Nature.

[30]  Christof M Niemeyer,et al.  Magneto immuno-PCR: a novel immunoassay based on biogenic magnetosome nanoparticles. , 2007, Biochemical and biophysical research communications.

[31]  Yuval Kluger,et al.  A Tissue Quality Index – an Intrinsic Control for Measurement of Effects of Pre-analytical Variables on FFPE Tissue , 2014, Laboratory Investigation.

[32]  Helen M. Moore,et al.  A review of preanalytical factors affecting molecular, protein, and morphological analysis of formalin-fixed, paraffin-embedded (FFPE) tissue: how well do you know your FFPE specimen? , 2014, Archives of pathology & laboratory medicine.

[33]  G. Nuovo,et al.  The Effect of Aging of Formalin-fixed Paraffin-embedded Tissues on the In Situ Hybridization and Immunohistochemistry Signals in Cervical Lesions , 2013, Diagnostic molecular pathology : the American journal of surgical pathology, part B.

[34]  D. Sahoo,et al.  Multiple Subsets of Brain Tumor Initiating Cells Coexist in Glioblastoma , 2016, Stem cells.

[35]  N. Palanisamy,et al.  Determination of Optimum Formalin Fixation Duration for Prostate Needle Biopsies for Immunohistochemistry and Quantum Dot FISH Analysis , 2015, Applied immunohistochemistry & molecular morphology : AIMM.

[36]  G. Wilding,et al.  Delay to formalin fixation effect on breast biomarkers , 2009, Modern Pathology.

[37]  J. Medema,et al.  Human colonic fibroblasts regulate stemness and chemotherapy resistance of colon cancer stem cells , 2016, Cell cycle.

[38]  S. Asthana,et al.  A natural killer–dendritic cell axis defines checkpoint therapy–responsive tumor microenvironments , 2018, Nature Medicine.

[39]  Yuval Kluger,et al.  Quantitative assessment of effect of preanalytic cold ischemic time on protein expression in breast cancer tissues. , 2012, Journal of the National Cancer Institute.

[40]  R. Joerger,et al.  High sensitivity multianalyte immunoassay using covalent DNA-labeled antibodies and polymerase chain reaction. , 1995, Nucleic acids research.

[41]  C R Cantor,et al.  Immuno-PCR: very sensitive antigen detection by means of specific antibody-DNA conjugates. , 1992, Science.

[42]  Lieping Chen,et al.  A Paradigm Shift in Cancer Immunotherapy: From Enhancement to Normalization , 2018, Cell.

[43]  Martin L. Miller,et al.  Mutational landscape determines sensitivity to PD-1 blockade in non–small cell lung cancer , 2015, Science.

[44]  A. Broeks,et al.  Neoadjuvant versus adjuvant ipilimumab plus nivolumab in macroscopic stage III melanoma , 2018, Nature Medicine.

[45]  M. Croft Control of immunity by the TNFR-related molecule OX40 (CD134). , 2010, Annual review of immunology.

[46]  Alexander Roesch,et al.  A Temporarily Distinct Subpopulation of Slow-Cycling Melanoma Cells Is Required for Continuous Tumor Growth , 2010, Cell.

[47]  M. Herlyn,et al.  Comparative Secretome Analysis of Epithelial and Mesenchymal Subpopulations of Head and Neck Squamous Cell Carcinoma Identifies S100A4 as a Potential Therapeutic Target* , 2013, Molecular & Cellular Proteomics.

[48]  Merrick I Ross,et al.  Neoadjuvant Immune Checkpoint Blockade in High-Risk Resectable Melanoma , 2018, Nature Medicine.

[49]  Hakho Lee,et al.  Photocleavable DNA barcode-antibody conjugates allow sensitive and multiplexed protein analysis in single cells. , 2012, Journal of the American Chemical Society.

[50]  Sean C. Bendall,et al.  A Structured Tumor-Immune Microenvironment in Triple Negative Breast Cancer Revealed by Multiplexed Ion Beam Imaging , 2018, Cell.

[51]  L. Chung,et al.  Stromal-epithelial interaction in prostate cancer progression. , 2006, Clinical genitourinary cancer.

[52]  Tomoko Fujita,et al.  Functional characterization of OX40 expressed on human CD8+ T cells. , 2006, Immunology letters.

[53]  R. Broaddus,et al.  Validation of Immunohistochemical Assays for Integral Biomarkers in the NCI-MATCH EAY131 Clinical Trial , 2017, Clinical Cancer Research.

[54]  Bernd Bodenmiller,et al.  Multiplexed Epitope-Based Tissue Imaging for Discovery and Healthcare Applications. , 2016, Cell systems.

[55]  Terence P. Speed,et al.  A new normalization for the Nanostring nCounter gene expression assay , 2018, bioRxiv.

[56]  C. Mirkin,et al.  Nanoparticle-Based Bio-Bar Codes for the Ultrasensitive Detection of Proteins , 2003, Science.

[57]  Do-Hyun Nam,et al.  Single-cell mRNA sequencing identifies subclonal heterogeneity in anti-cancer drug responses of lung adenocarcinoma cells , 2015, Genome Biology.

[58]  Hanlee P. Ji,et al.  Multiplexed protein detection by proximity ligation for cancer biomarker validation , 2007, Nature Methods.

[59]  J. Gartner,et al.  Prospective identification of neoantigen-specific lymphocytes in the peripheral blood of melanoma patients , 2016, Nature Medicine.

[60]  J. Buhmann,et al.  Highly multiplexed imaging of tumor tissues with subcellular resolution by mass cytometry , 2014, Nature Methods.

[61]  D. Allred,et al.  Progesterone receptor by immunohistochemistry and clinical outcome in breast cancer: a validation study , 2004, Modern Pathology.

[62]  Y. P. Bao,et al.  Detection of protein analytes via nanoparticle-based bio bar code technology. , 2006, Analytical chemistry.

[63]  Bernd Bodenmiller,et al.  miCAT: A toolbox for analysis of cell phenotypes and interactions in multiplex image cytometry data , 2017, Nature Methods.

[64]  M. Stratton,et al.  Tumor exome analysis reveals neoantigen-specific T-cell reactivity in an ipilimumab-responsive melanoma. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[65]  M. Hattori,et al.  Comprehensive single-cell transcriptome analysis reveals heterogeneity in endometrioid adenocarcinoma tissues , 2017, Scientific Reports.